Labcorp Perspectives Oncology: Rethinking how we track and treat cancer

At this year’s ASCO meeting in Chicago, HER2 stole the spotlight. In our latest episode of Labcorp Perspectives: Oncology, Dr. Rebecca Previs speaks with Dr. Michelle Green, Senior Manager of Oncology Genomics at Labcorp, about the most compelling takeaways from the conference and what they mean for the future of cancer diagnostics and treatment. With topics ranging from HER2 dynamics to the promise of liquid biopsy, this episode offers an insider’s look at how Labcorp is powering innovation in oncology.